Brain and Mind Centre
Camperdown, New South Wales, Australia
Research institute in Camperdown, New South Wales
94 Mallett St, Camperdown NSW 2050
About Brain and Mind Centre
The University of Sydney's Brain and Mind Centre was established for the research and treatment of disorders of the brain and mind. Child development and behaviour, mental health, and ageing and neurodegeneration are among the greatest health challenges of the 21st century.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Brain and Mind Centre
During the past decade, Brain and Mind Centre conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients
2015-01-12
2021-07-12
Completed
119
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
2017-03-24
2024-08-15
Active, not recruiting
1,239
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
2018-06-21
2020-07-23
Completed
496
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
2019-08-12
2028-04-04
Recruiting
1,000
An Efficacy and Safety Study of Ravulizumab in ALS Participants
2020-03-30
2021-10-17
Terminated
382
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
2020-10-26
2026-12-18
Recruiting
946
MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS)
2020-09-30
2024-03-01
Active, not recruiting
249
A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)
2021-08-16
2023-03-31
Terminated
486
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Brain and Mind Centre" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Alexion" with 2 trials
sponsored, "Apellis Pharmaceuticals, Inc." with 1 trials sponsored, "Cytokinetics" with 1 trials sponsored and "MapLight Therapeutics"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
Clinical Trials Conditions at Brain and Mind Centre
According to Clinical.Site data, the most researched conditions in "Brain and Mind Centre" are
"Amyotrophic Lateral Sclerosis" (4 trials), "Multiple Sclerosis, Primary Progressive" (2 trials), "ALS" (1 trials), "Autism Spectrum Disorder" (1 trials) and "Motor Neuron Disease" (1 trials). Many other conditions were trialed in "Brain and Mind Centre" in a lesser frequency.
Clinical Trials Intervention Types at Brain and Mind Centre
Most popular intervention types in "Brain and Mind Centre" are "Drug" (8 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Ocrelizumab" (3 trials), "Fenebrutinib" (1 trials), "Levosimendan" (1 trials) and "ML-004 (IR)/(ER) tablet" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Brain and Mind Centre
The vast majority of trials in "Brain and Mind Centre" are
9 trials for "All" genders.
Clinical Trials Status at Brain and Mind Centre
Currently, there are NaN active trials in "Brain and Mind Centre".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Brain and Mind Centre,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Brain and Mind Centre, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".